December 02, 2016 11:56 PM ET

Biotechnology

Company Overview of Enumeral Biomedical Holdings, Inc.

Key Executives for Enumeral Biomedical Holdings, Inc.

NameBoard RelationshipsTitleAge
Wael Fayad 7 RelationshipsChairman, Chief Executive Officer and President--
Kevin G. Sarney CPANo RelationshipsChief Accounting Officer, Vice President of Finance and Treasurer51
Matthew A. Ebert No RelationshipsGeneral Counsel and Secretary--

Enumeral Biomedical Holdings, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Wael Fayad 7 RelationshipsEnumeral Biomedical Holdings, Inc.--
Barry C. Buckland Ph.D. 51 RelationshipsEnumeral Biomedical Holdings, Inc.68
Paul J. Sekhri 198 RelationshipsLycera Corp.58
Robert J. Easton 29 RelationshipsCraig Drill Capital Corporation71
Robert L. Van Nostrand BS 40 RelationshipsMetabolix, Inc.59
View All Board Members

Enumeral Biomedical Holdings, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Robert J. Easton29 Relationships3 Executives
Compensation Committee Paul J. Sekhri198 Relationships3 Executives
Nominating Committee Ph.D.Barry C. Buckland51 Relationships3 Executives
Corporate Governance Committee Ph.D.Barry C. Buckland51 Relationships3 Executives
Advisory Board Ph.D.Barry C. Buckland51 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
375.8K
Bonus
254.9K
Total Short Term Compensation
468.1K
Total Value of Options
33.7M
Compensation as of Fiscal Year
Enumeral Biomedical Holdings, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Arrowhead Pharmaceuticals, Inc. to Terminate David Lewis as Chief Scientific Officer, Effective December 13, 2016
December 01, 2016 9:46 PM ET
Kite Pharma, Inc. Appoints Jian Irish, PhD as Senior Vice President of Supply Chain
December 01, 2016 1:30 PM ET
Pieris Pharmaceuticals, Inc. Appoints Claude Knopf as Senior Vice President and Chief Business Officer
December 01, 2016 1:00 PM ET
Sangamo BioSciences Announces Executive Appointments
December 01, 2016 12:00 PM ET
Aimmune Therapeutics Appoints Scientific Advisory Board
December 01, 2016 12:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Enumeral Biomedical Holdings, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.